article Open AccessTop 1% cited
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy
Neurology · 2010 · Vol. 75(23) · pp. 2087–2096
Robert K. Heaton✉(Johns Hopkins University)David B. Clifford(Johns Hopkins University)Donald Franklin(Johns Hopkins University)Steven Paul Woods(Johns Hopkins University)Christopher F. Ake(Johns Hopkins University)Florin Vaida(Johns Hopkins University)Ronald J. Ellis(Johns Hopkins University)Scott Letendre(Johns Hopkins University)Thomas D. Marcotte(Johns Hopkins University)J. Hampton Atkinson(Johns Hopkins University)Mónica Rivera Mindt(Johns Hopkins University)Ofilio Vigil(Johns Hopkins University)Michael Taylor(Johns Hopkins University)Ann C. Collier(Johns Hopkins University)Christina M. Marra(Johns Hopkins University)Benjamin B. Gelman(Johns Hopkins University)Justin C. McArthur(Johns Hopkins University)Susan Morgello(Johns Hopkins University)David M. Simpson(Johns Hopkins University)J. Allen McCutchan(Johns Hopkins University)Ian Abramson(Johns Hopkins University)Anthony Gamst(Johns Hopkins University)Christine Fennema‐Notestine(Johns Hopkins University)Terry L. Jernigan(Johns Hopkins University)J. Wong(Johns Hopkins University)Igor Grant(Johns Hopkins University)For the CHARTER Group
Abstract
The most severe HAND diagnosis (HAD) was rare, but milder forms of impairment remained common, even among those receiving CART who had minimal comorbidities. Future studies should clarify whether early disease events (e.g., profound CD4 decline) may trigger chronic CNS changes, and whether early CART prevents or reverses these changes.
HIV Research and TreatmentHIV-related health complications and treatmentsCytomegalovirus and herpesvirus researchNeurocognitiveMedicineComorbidityCartDementiaInternal medicinePediatricsDiseasePsychiatryCognition
MeSH terms
Activities of Daily LivingAdultAlgorithmsCognition DisordersDisability EvaluationEnzyme-Linked Immunosorbent AssayFemaleHumansMaleMiddle AgedNeurologic ExaminationNeuropsychological TestsPsychiatric Status Rating ScalesRetrospective StudiesModels, Statistical
Funding
- National Institutes of Health
Citations
2,290
FWCI
35.31
field-weighted impact
References
34
Percentile
100%
vs. same field & year
Citations per year
Cited by
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy
AIDS · 2011 · 411 citations
HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment
Journal of Neurology · 2017 · 336 citations
Mental health and HIV/AIDS
AIDS · 2019 · 701 citations
References
Updated research nosology for HIV-associated neurocognitive disorders
Neurology · 2007 · 2,586 citations
Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
Archives of Neurology · 2008 · 824 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
